TickerFacts.

Compare

Rhythm Pharmaceuticals, Inc. vs Maravai Lifesciences Holdings, Inc. vs Lifevantage Corp vs Cryoport, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearRhythm Pharmaceuticals, Inc.
RYTM		Maravai Lifesciences Holdings, Inc.
MRVI		Lifevantage Corp
LFVN		Cryoport, Inc.
CYRX
Year ended2025-12-312025-12-312026-06-302025-12-31
Revenue$189.76M$185.74M$182.59M$176.18M
Revenue growth (YoY)+45.8%-28.3%-20.1%+12.4%
Gross margin89.7% (computed)18.3%77.6%47.1%
Operating margin-101.2%-115.9%3.3%-20.9%
Net margin-103.6%-70.4%2.8%44.4%
Net income-$196.54M-$130.77M$5.07M$78.30M
EPS (Diluted)-$3.11-$0.90$0.40$1.40
Operating cash flow-$115.67M-$57.57M$10.24M-$8.58M
Free cash flow-$116.63M-$70.72M$6.67M-$25.02M
Cash & equivalents$54.30M$216.89Mn/a$250.49M
Total assets$480.20M$770.58M$62.11M$764.99M
Total liabilities$210.17M$397.87M$28.52M$262.35M
Shareholders' equity$139.07M$212.38M$33.59M$502.64M
Return on year-end equity-141.3%-61.6%15.1%15.6%
Shares outstanding67.21Mn/a12.52M49.85M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearRhythm Pharmaceuticals, Inc.Maravai Lifesciences Holdings, Inc.Lifevantage CorpCryoport, Inc.
Latest$189.76M
Ended 2025-12-31		$185.74M
Ended 2025-12-31		$182.59M
Ended 2026-06-30		$176.18M
Ended 2025-12-31
1 year earlier$130.13M
Ended 2024-12-31		$259.19M
Ended 2024-12-31		$228.53M
Ended 2025-06-30		$156.77M
Ended 2024-12-31
2 years earlier$77.43M
Ended 2023-12-31		$288.94M
Ended 2023-12-31		$200.16M
Ended 2024-06-30		$168.66M
Ended 2023-12-31
3 years earlier$23.64M
Ended 2022-12-31		$883.00M
Ended 2022-12-31		$213.40M
Ended 2023-06-30		$237.28M
Ended 2022-12-31
4 years earlier$3.15M
Ended 2021-12-31		$799.24M
Ended 2021-12-31		$206.36M
Ended 2022-06-30		$222.61M
Ended 2021-12-31